文献速递糖尿病

HLA II类(DR、DQ、DP)基因分别与两项糖尿病预防试验中从血清转换到1型糖尿病发病的进展相关

HLA Class II (DR, DQ, DP) Genes Were Separately Associated With the Progression From Seroconversion to Onset of Type 1 Diabetes Among Participants in Two Diabetes Prevention Trials (DPT-1 and TN07).
PubMed 文献 · Diabetes Care · 2024-01-01

研究对糖尿病预防试验-1和口服胰岛素随机糖尿病预防试验中1216名参与者行HLAII基因靶向测序,用Cox回归评估与疾病进展的关联。发现DQA1-DQB1、DPA1-DPB1、DRB1-DRB3及DRB1单等位基因与进展存在关联,提示HLAII多态性影响从胰岛自身免疫到1型糖尿病的进展。

要点

  • DQA1*03:01-DQB1*03:02与进展风险升高相关(HR=1.25,P=3.50*10-3)。
  • 调整DQ后,DPA1*02:01-DPB1*11:01与进展风险升高相关(HR=1.98,P=0.021)。
  • 共享DRB1*03:01的DRB3单倍型与进展呈相反关联,提示DRB3作用。

核心结论

  • 结果提示HLAII多态性影响具有胰岛自身抗体的高危受试者从胰岛自身免疫到1型糖尿病的进展。

研究设计与样本

  • 采用下一代靶向测序对来自糖尿病预防试验-1和口服胰岛素随机糖尿病预防试验的1216名参与者行8个HLAII基因(DQA1、DQB1、DRB1、DRB3、DRB4、DRB5、DPA1、DPB1)基因分型。
  • 通过连锁不平衡构建DQ、DP和DR单倍型,并结合可用临床协变量应用Cox回归模型评估HLAII免疫原性关联与疾病进展。

主要发现

  • 本次研究更新了既往报道的DQA1*03:01-DQB1*03:02(HR=1.25,P=3.50*10-3)和DQA1*03:03-DQB1*03:01(HR=0.56,P=1.16*10-3)遗传关联,并新发现DQA1*05:01-DQB1*02:01的风险关联(HR=1.19,P=0.041)。
  • 调整DQ后,DPA1*02:01-DPB1*11:01和DPA1*01:03-DPB1*03:01与进展呈相反关联(HR分别为1.98和0.70,P分别为0.021和6.16*10-3)。
  • 共享DRB1*03:01的DRB1*03:01-DRB3*01:01和DRB1*03:01-DRB3*02:02呈相反关联(HR分别为0.73和1.44,P分别为0.04和0.019),提示DRB3的作用。
  • DRB1*12:01-DRB3*02:02和DRB1*01:03单独与进展相关(HR分别为2.6和2.32,P分别为0.018和0.039)。
  • 通过枚举所有异二聚体,发现DQ和DP均可与疾病进展存在关联。

关键数值与推荐

  • DQA1*03:01-DQB1*03:02的HR=1.25(P=3.50*10-3)。
  • DQA1*03:03-DQB1*03:01的HR=0.56(P=1.16*10-3)。
  • DQA1*05:01-DQB1*02:01的HR=1.19(P=0.041)。
  • DPA1*02:01-DPB1*11:01的HR=1.98(P=0.021),DPA1*01:03-DPB1*03:01的HR=0.70(P=6.16*10-3)。
  • DRB1*03:01-DRB3*01:01的HR=0.73(P=0.04),DRB1*03:01-DRB3*02:02的HR=1.44(P=0.019);DRB1*12:01-DRB3*02:02的HR=2.6(P=0.018),DRB1*01:03的HR=2.32(P=0.039)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To explore associations of HLA class II genes (HLAII) with the progression of islet autoimmunity from asymptomatic to symptomatic type 1 diabetes (T1D). RESEARCH DESIGN AND METHODS: Next-generation targeted sequencing was used to genotype eight HLAII genes (DQA1, DQB1, DRB1, DRB3, DRB4, DRB5, DPA1, DPB1) in 1,216 participants from the Diabetes Prevention Trial-1 and Randomized Diabetes Prevention Trial with Oral Insulin sponsored by TrialNet. By the linkage disequilibrium, DQA1 and DQB1 are haplotyped to form DQ haplotypes; DP and DR haplotypes are similarly constructed. Together with available clinical covariables, we applied the Cox regression model to assess HLAII immunogenic associations with the disease progression. RESULTS: First, the current investigation updated the previously reported genetic associations of DQA1*03:01-DQB1*03:02 (hazard ratio [HR] = 1.25, P = 3.50*10-3) and DQA1*03:03-DQB1*03:01 (HR = 0.56, P = 1.16*10-3), and also uncovered a risk association with DQA1*05:01-DQB1*02:01 (HR = 1.19, P = 0.041). Second, after adjusting for DQ, DPA1*02:01-DPB1*11:01 and DPA1*01:03-DPB1*03:01 were found to have opposite associations with progression (HR = 1.98 and 0.70, P = 0.021 and 6.16*10-3, respectively). Third, DRB1*03:01-DRB3*01:01 and DRB1*03:01-DRB3*02:02, sharing the DRB1*03:01, had opposite associations (HR = 0.73 and 1.44, P = 0.04 and 0.019, respectively), indicating a role of DRB3. Meanwhile, DRB1*12:01-DRB3*02:02 and DRB1*01:03 alone were found to associate with progression (HR = 2.6 and 2.32, P = 0.018 and 0.039, respectively). Fourth, through enumerating all heterodimers, it was found that both DQ and DP could exhibit associations with disease progression. CONCLUSIONS: These results suggest that HLAII polymorphisms influence progression from islet autoimmunity to T1D among at-risk subjects with islet autoantibodies.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Zhao LP, Papadopoulos GK, Skyler JS, et al. HLA Class II (DR, DQ, DP) Genes Were Separately Associated With the Progression From Seroconversion to Onset of Type 1 Diabetes Among Participants in Two Diabetes Prevention Trials (DPT-1 and TN07). Diabetes Care. 2024. PMID: 38498185. doi:10.2337/dc23-1947

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。